Interest Expense of Merck & Co., Inc. from 31 Mar 2010 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Merck & Co., Inc. quarterly and annual Interest Expense in USD history and change rate from 31 Mar 2010 to 31 Mar 2024.
  • Merck & Co., Inc. Interest Expense for the quarter ending 31 Mar 2024 was $303,000,000, a 25% increase year-over-year.
  • Merck & Co., Inc. Interest Expense for the twelve months ending 31 Mar 2024 was $1,207,000,000, a 26% increase year-over-year.
  • Merck & Co., Inc. annual Interest Expense for 2023 was $1,146,000,000, a 19% increase from 2022.
  • Merck & Co., Inc. annual Interest Expense for 2022 was $962,000,000, a 19% increase from 2021.
  • Merck & Co., Inc. annual Interest Expense for 2021 was $806,000,000, a 3% decline from 2020.
Source SEC data
View on sec.gov
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Merck & Co., Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $1,207,000,000 $303,000,000 +$61,000,000 +25% 01 Jan 2024 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $1,146,000,000 $310,000,000 +$75,000,000 +32% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2024 2023 FY
Q3 2023 $1,071,000,000 $317,000,000 +$73,000,000 +30% 01 Jul 2023 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $998,000,000 $277,000,000 +$37,000,000 +15% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $961,000,000 $242,000,000 -$1,000,000 -0.41% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024 2024 Q1
Q4 2022 $962,000,000 $235,000,000 +$27,000,000 +13% 01 Oct 2022 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $935,000,000 $244,000,000 +$48,000,000 +24% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 $887,000,000 $240,000,000 +$38,000,000 +19% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 $849,000,000 $243,000,000 +$43,000,000 +22% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 $806,000,000 $208,000,000 +$1,000,000 +0.48% 01 Oct 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
Q3 2021 $805,000,000 $196,000,000 -$7,000,000 -3.4% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $812,000,000 $202,000,000 -$7,000,000 -3.3% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2021 $819,000,000 $200,000,000 -$12,000,000 -5.7% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $831,000,000 $207,000,000 -$13,000,000 -5.9% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2023 2022 FY
Q3 2020 $844,000,000 $203,000,000 -$28,000,000 -12% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3
Q2 2020 $872,000,000 $209,000,000 -$24,000,000 -10% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $896,000,000 $212,000,000 +$3,000,000 +1.4% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 $893,000,000 $220,000,000 +$17,000,000 +8.4% 01 Oct 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
Q3 2019 $876,000,000 $231,000,000 +$41,000,000 +22% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $835,000,000 $233,000,000 +$39,000,000 +20% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $796,000,000 $209,000,000 +$24,000,000 +13% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q4 2018 $772,000,000 $203,000,000 +$13,000,000 +6.8% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
Q3 2018 $759,000,000 $190,000,000 +$1,000,000 +0.53% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019 2019 Q3
Q2 2018 $758,000,000 $194,000,000 +$1,000,000 +0.52% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2019 Q2
Q1 2018 $757,000,000 $185,000,000 +$3,000,000 +1.6% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q4 2017 $754,000,000 $190,000,000 +$10,000,000 +5.6% 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
Q3 2017 $744,000,000 $189,000,000 +$19,000,000 +11% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018 2018 Q3
Q2 2017 $725,000,000 $193,000,000 +$22,000,000 +13% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $703,000,000 $182,000,000 +$10,000,000 +5.8% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q4 2016 $693,000,000 $180,000,000 +$11,000,000 +6.5% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
Q3 2016 $682,000,000 $170,000,000 +$5,000,000 +3% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $677,000,000 $171,000,000 -$3,000,000 -1.7% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $680,000,000 $172,000,000 +$8,000,000 +4.9% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q4 2015 $672,000,000 $169,000,000 +$4,000,000 +2.4% 01 Oct 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
Q3 2015 $668,000,000 $165,000,000 -$26,000,000 -14% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016 2016 Q3
Q2 2015 $694,000,000 $174,000,000 -$14,000,000 -7.4% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2
Q1 2015 $708,000,000 $164,000,000 -$24,000,000 -13% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q4 2014 $732,000,000 $165,000,000 -$36,000,000 -18% 01 Oct 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
Q3 2014 $768,000,000 $191,000,000 -$24,000,000 -11% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2015 Q3
Q2 2014 $792,000,000 $188,000,000 -$13,000,000 -6.5% 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q2
Q1 2014 $805,000,000 $188,000,000 +$4,000,000 +2.2% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q4 2013 $801,000,000 $201,000,000 +$12,000,000 +6.3% 01 Oct 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
Q3 2013 $789,000,000 $215,000,000 +$37,000,000 +21% 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014 2014 Q3
Q2 2013 $752,000,000 $201,000,000 +$29,000,000 +17% 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014 2014 Q2
Q1 2013 $723,000,000 $184,000,000 +$9,000,000 +5.1% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q4 2012 $714,000,000 $189,000,000 +$26,000,000 +16% 01 Oct 2012 31 Dec 2012 10-K 27 Feb 2015 2014 FY
Q3 2012 $688,000,000 $178,000,000 +$2,000,000 +1.1% 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013 2013 Q3
Q2 2012 $686,000,000 $172,000,000 +$2,000,000 +1.2% 01 Apr 2012 30 Jun 2012 10-Q 07 Aug 2013 2013 Q2
Q1 2012 $684,000,000 $175,000,000 -$11,000,000 -5.9% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1
Q4 2011 $695,000,000 $163,000,000 -$13,000,000 -7.4% 01 Oct 2011 31 Dec 2011 10-K 27 Feb 2014 2013 FY
Q3 2011 $708,000,000 $176,000,000 +$3,000,000 +1.7% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012 2012 Q3
Q2 2011 $705,000,000 $170,000,000 -$15,000,000 -8.1% 01 Apr 2011 30 Jun 2011 10-Q 07 Aug 2012 2012 Q2
Q1 2011 $720,000,000 $186,000,000 +$5,000,000 +2.8% 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012 2012 Q1
Q4 2010 $715,000,000 $176,000,000 01 Oct 2010 31 Dec 2010 10-K 28 Feb 2013 2012 FY
Q3 2010 $173,000,000 01 Jul 2010 30 Sep 2010 10-Q 08 Nov 2011 2011 Q3
Q2 2010 $185,000,000 01 Apr 2010 30 Jun 2010 10-Q 08 Aug 2011 2011 Q2
Q1 2010 $181,000,000 01 Jan 2010 31 Mar 2010 10-Q 09 May 2011 2011 Q1

Merck & Co., Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $1,146,000,000 +$184,000,000 +19% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2024 2023 FY
2022 $962,000,000 +$156,000,000 +19% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2024 2023 FY
2021 $806,000,000 -$25,000,000 -3% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
2020 $831,000,000 -$62,000,000 -6.9% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2023 2022 FY
2019 $893,000,000 +$121,000,000 +16% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $772,000,000 +$18,000,000 +2.4% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $754,000,000 +$61,000,000 +8.8% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $693,000,000 +$21,000,000 +3.1% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $672,000,000 -$60,000,000 -8.2% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $732,000,000 -$69,000,000 -8.6% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $801,000,000 +$87,000,000 +12% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
2012 $714,000,000 +$19,000,000 +2.7% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015 2014 FY
2011 $695,000,000 -$20,000,000 -2.8% 01 Jan 2011 31 Dec 2011 10-K 27 Feb 2014 2013 FY
2010 $715,000,000 01 Jan 2010 31 Dec 2010 10-K 28 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.